Q1 2018

Filed May 21, 2018 · 10-Q · 51 days after period end · 0001121781-18-000024

Q1 2018 · 10-Q

Revenue

$4.00K

−81.0% vs Q1 2017

Net Income

$1.08M

N/M vs Q1 2017

EPS Diluted

$0.00

N/M vs Q1 2017

Gross Profit$1,000−80.0%

Operating Income

Same quarter

Metric	Q1 2018	Q1 2017	Q1 2016	Q1 2015
Revenue	$4.00K	$21.00K	—	—
Net Income	$1.08M	-$107.00K	$130.00K	-$1.25M
EPS Diluted	$0.00	-$0.22	$0.00	-$1.31

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR